investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Pre-Leukemic Hematopoietic Stem Cells and Clonal Evolution in Human AML
Ravindra Majeti
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Ravindra Majeti
Stanford University
Stanford, United States
Related projects
Alan Rein
Retrovirus Assembly And Maturation
Leukaemia
Hematology and hematologic malignancies
Edward W Harhaj
Mechanisms of HTLV-I Tax Mediated NF-kB Activation
Leukaemia
Hematology and hematologic malignancies
Thomas Waldmann
IL-2/IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
Leukaemia
Hematology and hematologic malignancies
Peter Aplan
Pre-clinical Studies of Therapy for Myelodysplastic Syndrome
Leukaemia
Hematology and hematologic malignancies
Giovanna Tosato
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
Leukaemia
Hematology and hematologic malignancies
Stephen V Desiderio
Temporal and Spatial Control of V(D)J Recombination
Leukaemia
Hematology and hematologic malignancies
Robert Kreitman
Development of Recombinant Toxins to Treat Hematologic Malignancies
Leukaemia
Hematology and hematologic malignancies
Christophe P Nicot
HTLV-I Tax induces DNA Breaks and Inhibits HR Repair through Activation of NF-kB
Leukaemia
Hematology and hematologic malignancies
Clark W Distelhorst
Targeting PKM2-InsP3R interaction to treat AML
Leukaemia
Hematology and hematologic malignancies
